Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

853 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Active, Not Recruiting

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT06722157

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +3 more
Locations
  • Associated Retina Consultants Gilbert, Arizona, United States
  • Associated Retina Consultants, Ltd. Phoenix, Arizona, United States
  • Phoenix Retina Associates Phoenix, Arizona, United States
  • Retina Macula Institute of Arizona Scottsdale, Arizona, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

NCT06961370

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Associated Retina Consultants - Phoenix - DocTrials - PPDS Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center Sun City, Arizona, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Global Research Management Glendale, California, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

NCT04567303

Conditions
Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • Associated Retina Consultants Phoenix, Arizona, United States
  • The Retina Partners Encino, California, United States
  • Retinal Consultants Med Group Sacramento, California, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

NCT04704921

Conditions
AMD, CNV, Choroid Diseases, +18 more
Locations
  • Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
  • Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States
View all 89 locations
View Trial Details
Active, Not Recruiting

PRIMA US-Feasibility Study in Atrophic Dry AMD

NCT03392324

Conditions
Dry Age-related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Byers Eye Institute-Stanford University Palo Alto, California, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • UPMC Eye Center Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)

NCT06196840

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +2 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Zhejiang University Eye Hospital Hangzhou, Zhejiang, China
  • Peking Union Medical College Hospital Beijing, China
  • West China Hospital of Sichuan University Chengdu, China
View Trial Details

Related conditions